Although the edible alga Petalonia binghamiae is extensively consumed as a health-promoting food by Northeast Asians, little is known about the biomedical efficacies of P. binghamiae. In this report, we investigated the novel efficacy of P. binghamiae extract (Pb-E01) using LX-2 and HepG2 cells. Pb-E01 inhibited TGF-β1-induced cell proliferation and gene expression in LX-2 cells. In addition, Pb-E01 reduced H2O2–induced reactive oxygen species (ROS) and alanine aminotransferase (ALT) activity in HepG2 cells. According to these results, we suggest that Pb-E01 plays a functional role in suppressing liver fibrogenesis.
NairD.G., WeiskirchenR., Al-MusharafiS.K. (2015) The use of marine-derived bioactive compounds as potential hepatoprotective agents. Acta Pharmacologica Sinica, 36, 158–170.
2.
KarthikeyanR., SomasundaramaS.T., ManivasagamT., BalasubramanianT., AnantharamanP. (2010) Hepatoprotective activity of brown alga Padina boergesenii against CCl4 induced oxidative damage in Wistar rats. Asian Pacific Journal of Tropical Medicine, 3, 696–701.
3.
EsmatA.Y., SaidM.M., SolimanA.A., El-MasryK.S., BadieaE.A. (2013) Bioactive compounds, antioxidant potential, and hepatoprotective activity of sea cucumber (Holothuria atra) against thioacetamide intoxication in rats. Nutrition, 29, 258–267.
4.
SubhapradhaN., SaravananR., RamasamyP., SrinivasanA., ShanmugamV., ShanmugamA. (2014) Hepatoprotective effect of betachitosan from gladius of Sepioteuthis lessoniana against carbon tetrachloride-induced oxidative stress in Wistar rats. Applied Biochemistry and Biotechnology, 172, 9–20.
5.
MizushinaY., SugiyamaY., YoshidaH., HanashimaS., YamazakiT., KamisukiS., OhtaK., TakemuraM., YamaguchiT., MatsukageA., YoshidaS., SaneyoshiM., SugawaraF., SakagauchiK. (2001) Galactosyldiacylglycerol, a mammalian DNA polymerase alpha-specific inhibitor from a sea alga, Petalonia bingbamiae. Biological and Pharmaceutical Bulletin, 24, 982–987.
6.
MoriT., OoiT., HiraokaM., OkaN., HamadaH., TamuraM., KusumiT. (2004) Fucoxanthin and its metabolites in edible brown algae cultivated in deep seawater. Marine Drugs, 2, 63–72.
7.
KudaT., HishiT., MaekawaS. (2006) Antioxidant properties of dried product of 'haba-nori', an edible brown alga, Petalonia binghamiae (J. Agaradh) Vinogradova. Food Chemistry, 98, 545–50.
8.
FriedmanS.L. (2003) Liver fibrosis-from bench to bedside. Journal of Hepatology, 38, (Suppl. 1) S38–S53.
9.
BatallerR., BrennerD.A. (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Seminars in Liver Disease, 21, 437–451.
10.
ReevesH.L., FriedmanS.L. (2002) Activation of hepatic stellate cells: a key issue in liver fibrosis. Frontiers in Bioscience, 7, d808–d826.
11.
XuL., HuiA.Y., AlbanisE., ArthurM.J., O'ByrneS.M., BlanerW.S., MukherjeeP., FriedmanS.L., EngF.J. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut, 54: 142–151.
12.
KisselevaT., BrennerD.A. (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. Journal of Gastroenterology and Hepatology, 22, (Suppl. 1) S73–S78.
13.
ChenL., YuL.J., WaxmanD.J. (1997) Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene. Cancer Research, 57, 480–487.
14.
LotersztajnS., JulienB., Teixeira-ClercF., GrenardP., MallatA. (2005) Hepatic fibrosis: molecular mechanisms and drug targets. Annual Review of Pharmacology and Toxicology, 45, 605–628.
15.
SiegmundS.V., BrennerD.A. (2005) Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcoholism: Clinical and Experimental Research, 29, 102S–109S.
16.
GhouriN., PreissD., SattarN. (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology, 52, 1156–1161.
